SM-AHNMD
ORPHA: 98849
Overview
Human disease
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with SM-AHNMD, sourced from HPO and Orphanet clinical annotations.
Hematological neoplasmMyeloid leukemiaElevated total serum tryptaseAbnormal mast cell morphologyPallorPruritusWeight lossThrombocytopeniaIncreased total eosinophil countNormochromic anemiaNormocytic anemiaFeverIncreased total leukocyte countHeadacheMyeloproliferative disorderFatigueBone marrow hypercellularityOsteoporosisUrticariaSyncopeTachycardiaSplenomegalyDiarrheaNauseaAbdominal painAbnormality of the respiratory systemHepatomegalyHypotensionBone painIncreased susceptibility to fracturesLymphomaLymphadenopathyArthralgiaMyelodysplasiaMyalgiaPeptic ulcerAcute myeloid leukemiaIncreased total neutrophil countGranulocytic hyperplasiaChronic myelomonocytic leukemiaFlushingIncreased total basophil countChronic lymphatic leukemiaMultiple myelomaAmyloid deposition
Classification & Codes
Orphanet Code
ORPHA:98849SM-AHNMD
| Orphanet | ORPHA:98849 |
| Treatments | 0 drug(s) |
| Symptoms on record | 45 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO